The effect of dapagliflozin on the microvascular endothelial cell function and metabolism in patients with heart failure: a preliminary report

18 May 2025 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Vericiguat, SGLT2 inhibitors and implementation Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by